Deep vein thrombosis occurring early postrenal transplant
Autor: | Varun Mamidi, Varun Kumar Bandi, Manikantan Shekar, Vamsi Krishna Makkena, Jayakumar Matcha |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Transplantation
medicine.medical_specialty medicine.diagnostic_test business.industry Deep vein Venography lcsh:Surgery Inferior vena cava filter lcsh:RD1-811 medicine.disease Thrombosis Inferior vena cava Surgery Pulmonary embolism inferior vena cava filter medicine.anatomical_structure medicine.vein renal transplant medicine cardiovascular system Deep venous thrombosis business Lower limbs venous ultrasonography |
Zdroj: | Indian Journal of Transplantation, Vol 13, Iss 1, Pp 42-45 (2019) |
ISSN: | 2212-0025 2212-0017 |
Popis: | In kidney transplant recipients (KTRs), there can be an increased risk of thrombotic diseases. Here, we report a case of KTR, who developed ipsilateral acute iliofemoral deep vein thrombosis (DVT). A 38-year-old male with end-stage renal disease underwent deceased donor renal transplantation. He received antithymocyte globulin induction (2 mg/kg) and was maintained on tacrolimus, mycophenolate mofetil, and steroids. He had delayed graft function. One month posttransplant, the patient presented with right lower limb edema, with Doppler showing DVT of the right external iliac, common femoral, and proximal superficial femoral veins. He was treated with unfractionated heparin and underwent placement of retrieval filter in the infrarenal inferior vena cava (IVC) through the right internal jugular vein approach. Heparin was overlapped and switched to oral acenocoumarol. At 3 months postoperative, the patient is stable with no limb edema and serum creatinine of 0.8 mg/dl. A follow-up venous Doppler demonstrated the resolution of the thrombus. In conclusion, our patient developed DVT within 30-day postoperative period with no apparent risk factor and was successfully treated with anticoagulation and placement of IVC filter. Venography, thrombolysis, and thrombectomy pose challenges in the KTRs because of increased risk of adverse effects such as bleeding, contrast-induced nephropathy, and pulmonary embolism. |
Databáze: | OpenAIRE |
Externí odkaz: |